Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burggraaf

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2017
Response to "Time of the Day and Magnitude of the Effect of a Drug on the QTc Interval"L Kervezee, J Burggraaf
British Journal of Clinical Pharmacology|June 27, 1998
Assessment of hepatic blood flow using continuous infusion of high clearance drugsR C Schoemaker, J Burggraaf, A F Cohen
International Journal of Laboratory Hematology|November 16, 2012
Preincubation in the Prothrombinase-induced Clotting Time test (PiCT) is necessary for in vitro evaluation of fondaparinux and to be avoided for the reversible, direct factor Xa inhibitor, rivaroxabanC Kluft, P Meijer, R Kret, et al.
British Journal of Clinical Pharmacology|October 1, 1996
Assessment of changes in liver blood flow after food intake--comparison of ICG clearance and echo-DopplerJ Burggraaf, H C Schoemaker, A F Cohen
Journal of Thrombosis and Haemostasis : JTH|November 13, 2012
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttalC Kluft, S O Skouby, J Jespersen, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developmentsJ P M Vrouwe, J Burggraaf, M Kloppenburg, et al.
Journal of Clinical Pharmacology|May 23, 1998
A phase I double-blind, placebo-controlled, single rising dose study to determine the safety, tolerability, and pharmacokinetics of oral YM934 in healthy male volunteersJ Burggraaf, R C Schoemaker, I J Terpstra, et al.
Thrombosis Research|July 4, 2001
No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteersM J Kemme, J Burggraaf, R C Schoemaker, et al.
British Journal of Clinical Pharmacology|June 27, 1998
The influence of nifedipine and captopril on liver blood flow in healthy subjectsJ Burggraaf, R C Schoemaker, J M Kroon, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteersJ Burggraaf, R C Schoemaker, E G Lentjes, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2017
Response to "Time of the Day and Magnitude of the Effect of a Drug on the QTc Interval"L Kervezee, J Burggraaf
British Journal of Clinical Pharmacology|June 27, 1998
Assessment of hepatic blood flow using continuous infusion of high clearance drugsR C Schoemaker, J Burggraaf, A F Cohen
International Journal of Laboratory Hematology|November 16, 2012
Preincubation in the Prothrombinase-induced Clotting Time test (PiCT) is necessary for in vitro evaluation of fondaparinux and to be avoided for the reversible, direct factor Xa inhibitor, rivaroxabanC Kluft, P Meijer, R Kret, et al.
British Journal of Clinical Pharmacology|October 1, 1996
Assessment of changes in liver blood flow after food intake--comparison of ICG clearance and echo-DopplerJ Burggraaf, H C Schoemaker, A F Cohen
Journal of Thrombosis and Haemostasis : JTH|November 13, 2012
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttalC Kluft, S O Skouby, J Jespersen, et al.
Osteoarthritis and Cartilage Open|December 7, 2022
Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developmentsJ P M Vrouwe, J Burggraaf, M Kloppenburg, et al.
Journal of Clinical Pharmacology|May 23, 1998
A phase I double-blind, placebo-controlled, single rising dose study to determine the safety, tolerability, and pharmacokinetics of oral YM934 in healthy male volunteersJ Burggraaf, R C Schoemaker, I J Terpstra, et al.
Thrombosis Research|July 4, 2001
No Influence of acute hypertriglyceridemia on plasma t-PA in healthy male volunteersM J Kemme, J Burggraaf, R C Schoemaker, et al.
British Journal of Clinical Pharmacology|June 27, 1998
The influence of nifedipine and captopril on liver blood flow in healthy subjectsJ Burggraaf, R C Schoemaker, J M Kroon, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 5, 2000
Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteersJ Burggraaf, R C Schoemaker, E G Lentjes, et al.
Pageof 11